Structure-based Design for Medicinal Chemists

Author:

Blaney Jeff1,Davis Andrew M.2

Affiliation:

1. Small Molecule Drug Discovery, Genentech, 1 DNA Way South San Francisco CA 94080 USA blaney.jeff@gene.com

2. Hit Discovery, Discovery Sciences, R&D AstraZeneca Cambridge UK andy.davis@astrazeneca.com

Abstract

Structure-based design is an essential part of medicinal chemistry. The availability of experimental structures for many drug discovery targets and improvements in molecular modeling software makes it practical for medicinal chemists to do their own modeling and design. We will focus on how we've seen structure-based design performed during many medicinal chemistry projects in industry. Structure-based design relies most critically on a solid understanding of physical organic chemistry, especially conformational analysis and intra- and intermolecular interactions, and these aspects are covered in depth together with illustrative case studies. The amazing rapid advances in cryo-EM over the last several years are the most exciting and dramatic advance for structure-based design since the previous edition of this book. Those advances have enabled structure determination of membrane proteins and large protein complexes. The breakthroughs in protein structure prediction made by AlphaFold and RoseTTAFold are also considered. Future directions for application of structure-based drug design are considered including use of machine learning and large-scale virtual screening, and PROTAC and molecular glue design.

Publisher

The Royal Society of Chemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3